Lenalidomide and risk of second primary malignancy—is disease context key?. Issue 12 (December 2022)

Record Type:: Journal Article
Title:: Lenalidomide and risk of second primary malignancy—is disease context key?. Issue 12 (December 2022)
Main Title:: Lenalidomide and risk of second primary malignancy—is disease context key?
Authors:: Pawlyn, Charlotte
Bird, Sarah
Abstract:
Is Part Of:: Lancet. Volume 9:Issue 12(2022)
Journal:: Lancet
Issue:: Volume 9:Issue 12(2022)
Issue Display:: Volume 9, Issue 12 (2022)
Year:: 2022
Volume:: 9
Issue:: 12
Issue Sort Value:: 2022-0009-0012-0000
Page Start:: e868
Page End:: e869
Publication Date:: 2022-12
Subjects:: Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15005
Journal URLs:: http://www.sciencedirect.com/science/journal/23523026 ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2352-3026(22)00334-9 ↗
Languages:: English
ISSNs:: 2352-3026
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.081555
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24466.xml